AMT vs PLX · P/E 31, rev $10.64B vs P/E 31, rev $53.6M
American Tower Corp (AMT) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. Revenue was up 317.8% from 2024-12-31 to 2025-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported PLX revenue for 2026-06-30 was $53.6M. Net income was $22.1M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the AMT and PLX stock pages for the full models.
Not investment advice.